# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-23-081286
Filing Date
2023-10-10
Accepted
2023-10-10 07:00:45
Documents
43
Period of Report
2023-10-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | ea186520-8k_jasper.htm iXBRL | 8-K | 39591
2 | CORPORATE PRESENTATION, DATED OCTOBER 2023 | ea186520ex99-1_jasper.htm | EX-99.1 | 44004
3 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 159502
4 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 418711
5 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 313111
6 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 216208
7 | GRAPHIC | ex99-1_005.jpg | GRAPHIC | 253576
8 | GRAPHIC | ex99-1_006.jpg | GRAPHIC | 289531
9 | GRAPHIC | ex99-1_007.jpg | GRAPHIC | 220657
10 | GRAPHIC | ex99-1_008.jpg | GRAPHIC | 285455
11 | GRAPHIC | ex99-1_009.jpg | GRAPHIC | 257616
12 | GRAPHIC | ex99-1_010.jpg | GRAPHIC | 277664
13 | GRAPHIC | ex99-1_011.jpg | GRAPHIC | 130763
14 | GRAPHIC | ex99-1_012.jpg | GRAPHIC | 262615
15 | GRAPHIC | ex99-1_013.jpg | GRAPHIC | 175834
16 | GRAPHIC | ex99-1_014.jpg | GRAPHIC | 263046
17 | GRAPHIC | ex99-1_015.jpg | GRAPHIC | 306434
18 | GRAPHIC | ex99-1_016.jpg | GRAPHIC | 234207
19 | GRAPHIC | ex99-1_017.jpg | GRAPHIC | 265146
20 | GRAPHIC | ex99-1_018.jpg | GRAPHIC | 232489
21 | GRAPHIC | ex99-1_019.jpg | GRAPHIC | 339425
22 | GRAPHIC | ex99-1_020.jpg | GRAPHIC | 272588
23 | GRAPHIC | ex99-1_021.jpg | GRAPHIC | 273882
24 | GRAPHIC | ex99-1_022.jpg | GRAPHIC | 150763
25 | GRAPHIC | ex99-1_023.jpg | GRAPHIC | 318158
26 | GRAPHIC | ex99-1_024.jpg | GRAPHIC | 285968
27 | GRAPHIC | ex99-1_025.jpg | GRAPHIC | 265189
28 | GRAPHIC | ex99-1_026.jpg | GRAPHIC | 290560
29 | GRAPHIC | ex99-1_027.jpg | GRAPHIC | 186019
30 | GRAPHIC | ex99-1_028.jpg | GRAPHIC | 264421
31 | GRAPHIC | ex99-1_029.jpg | GRAPHIC | 170930
| Complete submission text file | 0001213900-23-081286.txt |  | 10483563

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
32 | XBRL SCHEMA FILE | jspr-20231010.xsd | EX-101.SCH | 3928
33 | XBRL DEFINITION FILE | jspr-20231010_def.xml | EX-101.DEF | 26833
34 | XBRL LABEL FILE | jspr-20231010_lab.xml | EX-101.LAB | 37093
35 | XBRL PRESENTATION FILE | jspr-20231010_pre.xml | EX-101.PRE | 25457
37 | EXTRACTED XBRL INSTANCE DOCUMENT | ea186520-8k_jasper_htm.xml | XML | 5621

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

EIN.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39138 | Film No.: 231315598
SIC: 2836 Biological Products, (No Diagnostic Substances)